The Impact of COVID-19 on Teledermatology : A Review - 21/09/21

Doi : 10.1016/j.det.2021.05.007

Cassandra B. Yeboah, BS, MBS ^a, Nailah Harvey, BS ^a, Rohan Krishnan ^b, Jules B. Lipoff, MD ^b,^c,^⁎
^a Philadelphia College of Osteopathic Medicine, 4170 City Avenue, Philadelphia, PA 19131, USA
^b Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 4170 City Avenue, Philadelphia, PA 19131, USA
^c Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA

^∗Corresponding author. Penn Medicine University City, 3737 Market Street, Suite 1100, Philadelphia, PA 19104.Penn Medicine University City3737 Market StreetSuite 1100PhiladelphiaPA19104

conectar o crear una cuenta

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Resumen

The accelerated implementation and use of teledermatology during the coronavirus disease 2019 pandemic has met with successes and challenges. This review explores how telemedicine was used in dermatology before the pandemic, the regulatory adaptions made in response to the pandemic, and the effectiveness of the rapid implementation of teledermatology during the coronavirus disease 2019 pandemic, and, finally, how teledermatology has expanded in response to the pandemic. This review examines lessons learned and how teledermatology's reliance on digital technologies might paradoxically exacerbate health care disparities, and finally, considers the future outlook.

El texto completo de este artículo está disponible en PDF.

Keywords : Teledermatology, COVID-19, Telemedicine, Telehealth, Store-and-forward teledermatology, Live-interactive teledermatology, Digital divide

Esquema

Key points

Introduction

Teledermatology before coronavirus disease 2019

Telemedicine regulatory changes in response to the coronavirus disease 2019 pandemic

Implementation of teledermatology during the coronavirus disease 2019 pandemic

Expansion of teledermatology during the coronavirus disease 2019 pandemic

Program-specific approaches to teledermatology

The impact of telemedicine for coronavirus disease 2019 on resident education

Lessons learned during the coronavirus disease 2019 pandemic

Patient Data Security

Teledermatology and the Digital Divide

Future outlook for teledermatology

Clinics care points

	Funding sources: None.
	Conflicts of Interest: Dr. Lipoff is the outgoing chair of the American Academy of Dermatology’s Teledermatology Task Force and a member of the Ad Hoc COVID-19 Task Force. He has served as a paid consultant on telemedicine for Havas Life Medicom and as telemedicine advisor for AcneAway, a direct-to-consumer teledermatology start-up.